Cargando…

Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers

Triple-negative breast cancer (TNBC) is a group of breast cancers which neither express hormonal receptors nor human epidermal growth factor receptor. Hence, there is a lack of currently known targeted therapies and the only available line of systemic treatment option is chemotherapy or more recentl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abd El-Aziz, Yomna S., Spillane, Andrew J., Jansson, Patric J., Sahni, Sumit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2021
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909869/ https://www.ncbi.nlm.nih.gov/pubmed/33543229 http://dx.doi.org/10.1042/BSR20204092

Ejemplares similares

Emerging Role of Autophagy in the Development and Progression of Oral Squamous Cell Carcinoma
por: Abd El-Aziz, Yomna S., et al.
Publicado: (2021)

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
por: Lin, Yueh-Te, et al.
Publicado: (2022)

RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer
por: Koh, Siang-Boon, et al.
Publicado: (2021)

Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
por: Gillson, Josef, et al.
Publicado: (2022)

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
por: Zhang, Haomeng, et al.
Publicado: (2021)

Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis
por: Zhao, Cui-Cui, et al.
Publicado: (2021)

The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015)

The hedgehog pathway in triple‐negative breast cancer
por: Habib, Joyce G., et al.
Publicado: (2016)

Novel strategies to target chemoresistant triple-negative breast cancer
por: Venkatesh, Jaganathan, et al.
Publicado: (2020)

DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
por: Ogbu, Stella C., et al.
Publicado: (2021)

The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
por: He, Lin, et al.
Publicado: (2021)

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression
por: Siddharth, Sumit, et al.
Publicado: (2021)

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
por: Agnello, Lisa, et al.
Publicado: (2023)

Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
por: Xu, Yonggang, et al.
Publicado: (2021)

Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
por: Weichhaus, Michael, et al.
Publicado: (2014)

Fascin‐1 as a novel diagnostic marker of triple‐negative breast cancer
por: Wang, Chao‐Qun, et al.
Publicado: (2016)

Early-stage Triple-negative Breast Cancer: Time to Optimize Personalized Strategies
por: Abuhadra, Nour, et al.
Publicado: (2022)

Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance
por: Robinson, Prema, et al.
Publicado: (2016)

Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines
por: Tiang, Jacky M, et al.
Publicado: (2015)

MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018)

RECQL5 plays an essential role in maintaining genome stability and viability of triple‐negative breast cancer cells
por: Peng, Jin, et al.
Publicado: (2019)

Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy Cycles
por: Miroshnychenko, Daria, et al.
Publicado: (2023)

Development and characterization of two human triple‐negative breast cancer cell lines with highly tumorigenic and metastatic capabilities
por: Su, Yanrong, et al.
Publicado: (2016)

Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
por: Bousquet, Guilhem, et al.
Publicado: (2017)

Expression and function of SLC38A5, an amino acid-coupled Na(+)/H(+) exchanger, in triple-negative breast cancer and its relevance to macropinocytosis
por: Ramachandran, Sabarish, et al.
Publicado: (2021)

Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple-negative breast cancer
por: Bao, Jean, et al.
Publicado: (2015)

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
por: Vinet, Mathilde, et al.
Publicado: (2019)

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer
por: Ding, Xiaorong, et al.
Publicado: (2020)

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
por: Fang, Wentong, et al.
Publicado: (2021)

Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy
por: Vernaci, Grazia, et al.
Publicado: (2023)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
por: Ghallab, Alaa M., et al.
Publicado: (2022)

Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer
por: de Paula, Bruno, et al.
Publicado: (2023)

Lapatinib Suppresses HER2-Overexpressed Cholangiocarcinoma and Overcomes ABCB1– Mediated Gemcitabine Chemoresistance
por: Bai, Zhiqing, et al.
Publicado: (2022)

NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway
por: Zheng, Qiao, et al.
Publicado: (2020)

MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
por: Ouyang, Mao, et al.
Publicado: (2014)

CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1
por: Luo, Hong, et al.
Publicado: (2021)

Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies
por: Chakrabarty, Anindita, et al.
Publicado: (2021)

The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2022)

LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer
por: Lo, Pang-Kuo, et al.
Publicado: (2018)

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target
por: Bousquet, Guilhem, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jse1j321h3rv4gnl60rtjji9j8